Vertex Pharmaceuticals Inc (VRTX)
484.17
-10.44
(-2.11%)
USD |
NASDAQ |
Nov 14, 16:00
483.73
-0.44
(-0.09%)
After-Hours: 20:00
Vertex Pharmaceuticals Cash and Short Term Investments (Quarterly): 6.524B for Sept. 30, 2024
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 6.524B |
| June 30, 2024 | 5.796B |
| March 31, 2024 | 10.17B |
| December 31, 2023 | 11.22B |
| September 30, 2023 | 11.93B |
| June 30, 2023 | 11.24B |
| March 31, 2023 | 10.41B |
| December 31, 2022 | 10.78B |
| September 30, 2022 | 9.771B |
| June 30, 2022 | 9.253B |
| March 31, 2022 | 8.238B |
| December 31, 2021 | 7.525B |
| September 30, 2021 | 6.961B |
| June 30, 2021 | 6.708B |
| March 31, 2021 | 6.924B |
| December 31, 2020 | 6.659B |
| September 30, 2020 | 6.151B |
| June 30, 2020 | 5.451B |
| March 31, 2020 | 4.190B |
| December 31, 2019 | 3.808B |
| September 30, 2019 | 3.996B |
| June 30, 2019 | 3.951B |
| March 31, 2019 | 3.478B |
| December 31, 2018 | 3.168B |
| September 30, 2018 | 3.056B |
| Date | Value |
|---|---|
| June 30, 2018 | 2.768B |
| March 31, 2018 | 2.477B |
| December 31, 2017 | 2.089B |
| September 30, 2017 | 1.812B |
| June 30, 2017 | 1.669B |
| March 31, 2017 | 1.409B |
| December 31, 2016 | 1.435B |
| September 30, 2016 | 1.128B |
| June 30, 2016 | 1.071B |
| March 31, 2016 | 1.026B |
| December 31, 2015 | 1.042B |
| September 30, 2015 | 1.006B |
| June 30, 2015 | 1.016B |
| March 31, 2015 | 1.181B |
| December 31, 2014 | 1.387B |
| September 30, 2014 | 1.478B |
| June 30, 2014 | 1.219B |
| March 31, 2014 | 1.324B |
| December 31, 2013 | 1.465B |
| September 30, 2013 | 1.423B |
| June 30, 2013 | 1.431B |
| March 31, 2013 | 1.239B |
| December 31, 2012 | 1.321B |
| September 30, 2012 | 1.299B |
| June 30, 2012 | 1.223B |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
3.808B
Minimum
Dec 2019
11.93B
Maximum
Sep 2023
7.985B
Average
7.243B
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| Eli Lilly and Co | 3.518B |
| Gilead Sciences Inc | 5.037B |
| Bristol-Myers Squibb Co | 8.094B |
| Moderna Inc | 6.867B |
| Sarepta Therapeutics Inc | 1.198B |